Segall Bryant & Hamill’s Carter's CRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-47,984
Closed -$4.06M 418
2024
Q1
$4.06M Sell
47,984
-72,053
-60% -$5.72M 0.08% 265
2023
Q4
$8.99M Buy
120,037
+11,934
+11% +$829K 0.17% 198
2023
Q3
$7.48M Sell
108,103
-21,898
-17% -$1.56M 0.09% 258
2023
Q2
$9.44M Buy
130,001
+3,815
+3% +$258K 0.1% 243
2023
Q1
$9.07M Sell
126,186
-198,572
-61% -$15.2M 0.1% 241
2022
Q4
$24.2M Buy
+324,758
New +$23.3M 0.27% 112
2018
Q4
Sell
-21,969
Closed -$2.17M 838
2018
Q3
$2.17M Sell
21,969
-1,526
-6% -$161K 0.03% 419
2018
Q2
$2.55M Buy
+23,495
New +$2.53M 0.04% 397

Other funds holding CRI

Segall Bryant & Hamill's CRI Position: Q2 2024 in Review

Segall Bryant & Hamill sold out of Carter's (CRI) in Q2 2024, closing a stake of 47,984 shares — an estimated $4.06M sold.

Segall Bryant & Hamill first reported a position in CRI in Q2 2018 and held it in 8 quarters. The position peaked at $24.2M in Q4 2022. 329 funds tracked by Wall St. Rank hold CRI as of Q2 2024.

  • Segall Bryant & Hamill reported no remaining Carter's position as of Q2 2024 after selling out during the quarter.
  • Segall Bryant & Hamill sold 47,984 Carter's shares in Q2 2024, an estimated $4.06M.
  • Segall Bryant & Hamill first reported a position in Carter's in Q2 2018 and held it in 8 quarters.
  • Segall Bryant & Hamill's Carter's position peaked at $24.2M in Q4 2022.
  • 329 funds tracked by Wall St. Rank held Carter's as of Q2 2024.

Based on Segall Bryant & Hamill's 13F filing for Q2 2024, filed 14 Aug 2024.